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Microlymphoma, A Rare Clinicopathologic Entity During the
Evolution of an Aggressive Lymphoma: A Case Report.
Andrew Heisel MS4, Arsha Sreedhar MD, Nicholas Lamparella DO, Ranjit Nair MD, Shereen M. Gheith MD, PhD
Lehigh Valley Health Network, Allentown, Pennsylvania, USA

Introduction:
We report a patient case presenting with generalized
lymphadenopathy on work-up diagnosed with HHV-8
associated Multicentric Castleman Disease (HHV-8+MCD)
with microlymphoma in the setting of newly diagnosed HIV.
Microlymphoma is a very rarely reported clinicopathological
entity, which is described as a precursor to aggressive
plasmablastic lymphoma (PBL), mostly seen in HIV patients.

Figure 1: A. B-cell follicle with expanded mantle zone infiltrated by numerous
large plasmablastic cells with dense amphophilic cytoplasm and nuclei with one
or two prominent nucleoli. B. Large follicle with confluent sheets of plasmablast
[hematoxylin-eosin, original magnifications X400].

Case:
A 57-year-old male presented to the ED with cough, SOB,
intermittent fevers and generalized weakness since three
weeks. Initial workup showed severe pancytopenia, normal
blood chemistry, elevated CRP 112 mg/L and peripheral
smear showing plasmacytoid and atypical lymphocytes.
An HIV assay was positive with decreased CD4/CD8 ratio.
Bone marrow biopsy showed hypercellularity, but no signs
of lymphoproliferative neoplasm. CT scan demonstrated
generalized lymphadenopathy with splenomegaly. The lymph
node biopsy showed an overall preserved architecture with
open sinuses and numerous interfollicular small plasma
cells. In focal areas, follicles with concentric layering of
plasmablasts within the mantle zone reminiscent of Castleman
disease were seen. These follicles were more expanded
in other areas with confluent sheets of plasmablasts (Fig.
1). Immunohistochemistry demonstrated the internodular
small plasma cells to be CD138+ with polytypic kappa and
lambda light chain expression. The clusters and nodules of
plasmablasts were lambda light chain restricted and HHV-8+
by in-situ hybridization (Fig. 2). The patient was initiated on
HAART therapy with rituximab. After 4-weeks of treatment, he
was seen in clinic with improved symptoms and normal counts.
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Figure 2: Immunohistochemistry shows CD138 -positive plasma cells (A) with subsets
expressing polytypic kappa and lambda light chain located in the internodular region
(C & D). Plasmablasts are lambda light chain restricted and are confined to the centers
of the follicles (blue circles) (D). Plasmablasts are positive for HHV-8 stain by in-situ
Hybridization (B) original magnifications X200 [A, B, C and D].

Discussion:
Microlymphoma is a rare intermediate clinicopathological
entity that is described during the evolution from HHV8+MCD to the onset of an aggressive PBL. Albeit having
no frank histopathologic evidence of aggressive lymphoma
in our patient, the clinical and histological features were
compatible with HHV-8+MCD with confluent clusters of HHV8+ plasmablasts coalescing to form microlymphomas. Given
the rarity of PBL and the poor prognosis associated with HIV/
HHV-8+ cases, understanding of the natural history of PBL is
important to initiate early treatment.

